Utility of Restricted Mean Survival Time for Analyzing Time to Nursing Home Placement Among Patients With Dementia

Authors:

Abstract
Delaying nursing home (NH) placement for patients with dementia is an important goal. The effect of a treatment for dementia on NH placement is conventionally summarized as a hazard ratio, risk difference, or median time difference. Recently, restricted mean survival time (RMST) has been proposed as an intuitive measure that summarizes treatment effect in terms of the difference in the number of event-free days.1-3 Despite its advantages over conventional measures (Table), to date, RMST has not been applied to clinical trials of dementia treatments. We assessed the utility of RMST in analyzing time to NH placement among patients with dementia using the Donepezil and Memantine in Moderate to Severe Alzheimer’s Disease (DOMINO-AD) trial as an example.4,5

This publication has 6 references indexed in Scilit: